New hope for tough leukemias: experimental drug APL-4098 enters human testing

NCT ID NCT06372717

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 22 times

Summary

This early-stage study tests an experimental drug called APL-4098, alone or with standard chemotherapy drugs, in about 100 adults with acute myeloid leukemia (AML) or related blood cancers that have come back or not responded to treatment. The main goals are to check safety, find the best dose, and see if the drug helps control the disease. Participants must be 18 or older and have tried other treatments without success.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA REFRACTORY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hollywood Private Hospital

    RECRUITING

    Nedlands, Western Australia, 6009, Australia

  • Monash Health

    RECRUITING

    Clayton, Victoria, 3168, Australia

  • Royal Perth Hospital

    RECRUITING

    Perth, Western Australia, 6000, Australia

  • Sarah Cannon Research Institute UK

    RECRUITING

    London, W1G 0PU, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • St. Vincent's Hospital Melbourne

    RECRUITING

    Fitzroy, Victoria, 3065, Australia

  • The Alfred Hospital

    RECRUITING

    Melbourne, Victoria, 3004, Australia

  • The Royal Marsden Hospital

    RECRUITING

    London, SM2 5PT, United Kingdom

Conditions

Explore the condition pages connected to this study.